Inquiry Basket
Loading ......
Infectious Bursal Disease Virus (IBDV), a member of the family Birnaviridae, is the causative agent of Infectious Bursal Disease (IBD), or Gumboro disease, a highly contagious and immunosuppressive ailment of young chickens. First identified in the 1960s, IBDV has since evolved into a pathogen of immense global economic significance in the poultry industry. The virus exhibits a pronounced tropism for actively dividing B-lymphocytes within the bursa of Fabricius, the primary site for B-cell development in birds. This targeted destruction leads to severe bursal atrophy, transient or permanent immunosuppression, and increased susceptibility to secondary infections. The emergence of very virulent (vv) and antigenic variant strains has complicated control efforts.
Figure 1. Schematic representation of the IBDV structure. (Rage E, et al. 2020)
Infectious Bursal Disease is considered one of the most economically damaging diseases in commercial poultry production worldwide. While acute forms of the disease cause direct mortality, the principal loss stems from the virus-induced immunosuppression. Afflicted flocks suffer from poor vaccine responses, increased condemnations at slaughter, and heightened vulnerability to opportunistic pathogens like Escherichia coli, Mycoplasma, and viruses such as Newcastle disease and Marek's disease virus. The control of IBD is therefore not only about preventing IBDV-induced mortality but, more critically, about protecting the overall immunological competence of the flock. Understanding IBDV's sophisticated strategy for targeting and destroying the avian immune system's command center is key to developing more effective countermeasures.
The IBDV genome is unique, consisting of two segments of double-stranded RNA (dsRNA):
Segment A (~3.2 kb): Encodes a polyprotein that is autocatalytically cleaved into the viral proteins VP2, VP3, and VP4. A smaller, overlapping open reading frame encodes the non-structural protein VP5.
Segment B (~2.8 kb): Encodes VP1, the RNA-dependent RNA polymerase (RdRp), which is responsible for genome replication and transcription. VP1 exists both as a free protein and as a genome-linked protein (VPg) covalently attached to the 5' ends of the genomic RNA segments.
| Host Targets | Details |
| Myeloid Differentiation Primary Response Gene 88 (MyD88) | A key adaptor protein in the Toll-like receptor (TLR) signaling pathway, which interacts with IBDV VP2 to activate NF-κB and induce pro-inflammatory cytokine production. Modulating MyD88 activity can reduce IBDV-induced inflammation and tissue damage. |
| NLRP3 Inflammasome | A host innate immune complex activated by IBDV infection, promoting caspase-1-dependent cleavage of IL-1β and IL-18. Activation of the NLRP3 inflammasome amplifies the inflammatory response, and its inhibition can reduce IBDV-induced tissue damage. |
| Interleukin-1β (IL-1β) | A pro-inflammatory cytokine whose production is significantly increased by IBDV infection through the VP2-MyD88-NF-κB pathway. IL-1β contributes to the acute inflammatory response in the bursa of Fabricius and is associated with disease severity. |
| Melanoma Differentiation-Associated Protein 5 (MDA5) | A host pattern recognition receptor (PRR) that recognizes IBDV dsRNA genome, initiating the innate immune response and inducing the production of interferons (IFNs). Since chickens lack RIG-I, MDA5 is the primary PRR responsible for detecting IBDV infection in poultry. |
Host Range and Susceptibility
Chickens are the primary natural host, with young birds between 3 and 6 weeks of age (when the bursa is most active) being most susceptible. Other avian species (turkeys, ducks) can be infected subclinically and may act as reservoirs.
Transmission and Environmental Stability
Viral RNA-Dependent RNA Polymerase VP1
Viral Protease VP4
Infectious Bursal Disease Virus stands as a formidable adversary in poultry health, masterfully evolved to exploit and destroy the developing avian immune system. Its economic impact through immunosuppression far outweighs acute mortality. The continuous evolution of antigenic and pathogenic strains demands vigilant surveillance and adaptive vaccine strategies. Deciphering the molecular dialogue between IBDV proteins and host cell machinery—from VP2-mediated entry and VP5-driven immune evasion to Hsp90-dependent assembly—has unveiled a rich landscape of potential targets for next-generation therapeutics and vaccines. A multifaceted approach combining robust vaccination, impeccable biosecurity, and advanced molecular insights is essential to mitigate the threat of this highly efficient immunosuppressive pathogen.
Reference
| Target | Cat. No. | Product Name | Host | |
| IBDV | DAGF-109 | Native Infectious Bursal Disease Virus Antigen | Chicken | Inquiry |
| DAGC552 | IBDV Serotype 1 (M4040 (2512)) Bursal Homogenate | N/A | Inquiry | |
| DAGC553 | IBDV Serotype 1 (M4040 (2512)) Allantoic Fluid | N/A | Inquiry | |
| DAGC554 | IBDV Serotype 1 (M4040 (2512)) Tissue Culture | N/A | Inquiry | |
| DAG-WT652 | Recombinant Infectious Bursal Disease Virus VP2 | E. coli | Inquiry |
Loading ......
